These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 29240608)

  • 1. Metabolic Profile of Ex Vivo Lung Perfusate Yields Biomarkers for Lung Transplant Outcomes.
    Hsin MK; Zamel R; Cypel M; Wishart D; Han B; Keshavjee S; Liu M
    Ann Surg; 2018 Jan; 267(1):196-197. PubMed ID: 29240608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of metabolomics to identify strategies to improve and prolong ex vivo lung perfusion for lung transplants.
    Shin J; Hsin MK; Baciu C; Chen Y; Zamel R; Machuca T; Yeung J; Cypel M; Keshavjee S; Liu M
    J Heart Lung Transplant; 2021 Jun; 40(6):525-535. PubMed ID: 33849769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantation.
    Kanou T; Nakahira K; Choi AM; Yeung JC; Cypel M; Liu M; Keshavjee S
    J Thorac Cardiovasc Surg; 2021 Aug; 162(2):490-499.e2. PubMed ID: 32928548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the endothelin-1 pathway as a biomarker for donor lung assessment in clinical ex vivo lung perfusion.
    Machuca TN; Cypel M; Zhao Y; Grasemann H; Tavasoli F; Yeung JC; Bonato R; Chen M; Zamel R; Chun YM; Guan Z; de Perrot M; Waddell TK; Liu M; Keshavjee S
    J Heart Lung Transplant; 2015 Jun; 34(6):849-57. PubMed ID: 25907141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended post-ex vivo lung perfusion cold preservation predicts primary graft dysfunction and mortality: Results from a multicentric study.
    Leiva-Juárez MM; Urso A; Arango Tomás E; Lederer DJ; Sanchez P; Griffith B; Davis RD; Daneshmand M; Hartwig M; Cantu E; Weyant MJ; Bermudez C; D'Cunha J; Machuca T; Wozniak T; Lynch W; Nemeh H; Mulligan M; Song T; Jessen M; Camp PC; Caldeira C; Whitson B; Kreisel D; Ramzy D; D'Ovidio F
    J Heart Lung Transplant; 2020 Sep; 39(9):954-961. PubMed ID: 32475748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling inflammation and tissue injury markers in perfusate and bronchoalveolar lavage fluid during human ex vivo lung perfusion.
    Andreasson AS; Karamanou DM; Gillespie CS; Özalp F; Butt T; Hill P; Jiwa K; Walden HR; Green NJ; Borthwick LA; Clark SC; Pauli H; Gould KF; Corris PA; Ali S; Dark JH; Fisher AJ
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):577-586. PubMed ID: 28082471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein expression profiling predicts graft performance in clinical ex vivo lung perfusion.
    Machuca TN; Cypel M; Yeung JC; Bonato R; Zamel R; Chen M; Azad S; Hsin MK; Saito T; Guan Z; Waddell TK; Liu M; Keshavjee S
    Ann Surg; 2015 Mar; 261(3):591-7. PubMed ID: 25371129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CLUE for better assessment of donor lungs: Novel technique in clinical ex vivo lung perfusion.
    Ayyat KS; Okamoto T; Niikawa H; Sakanoue I; Dugar S; Latifi SQ; Lebovitz DJ; Moghekar A; McCurry KR
    J Heart Lung Transplant; 2020 Nov; 39(11):1220-1227. PubMed ID: 32773324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal ex vivo lung perfusion techniques with oxygenated perfusate.
    Noda K; Tane S; Haam SJ; Hayanga AJ; D'Cunha J; Luketich JD; Shigemura N
    J Heart Lung Transplant; 2017 Apr; 36(4):466-474. PubMed ID: 27914896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of lung edema during ex-vivo lung perfusion by single transpulmonary thermodilution: A preliminary study in humans.
    Trebbia G; Sage E; Le Guen M; Roux A; Soummer A; Puyo P; Parquin F; Stern M; Pham T; Sakka SG; Cerf C;
    J Heart Lung Transplant; 2019 Jan; 38(1):83-91. PubMed ID: 30391201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of marginal donors for lung transplantation after ex vivo lung perfusion: A systematic review and meta-analysis.
    Tian D; Wang Y; Shiiya H; Sun CB; Uemura Y; Sato M; Nakajima J
    J Thorac Cardiovasc Surg; 2020 Feb; 159(2):720-730.e6. PubMed ID: 31548078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion.
    Andreasson ASI; Borthwick LA; Gillespie C; Jiwa K; Scott J; Henderson P; Mayes J; Romano R; Roman M; Ali S; Fildes JE; Marczin N; Dark JH; Fisher AJ;
    J Heart Lung Transplant; 2017 Sep; 36(9):985-995. PubMed ID: 28551353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK.
    Fisher A; Andreasson A; Chrysos A; Lally J; Mamasoula C; Exley C; Wilkinson J; Qian J; Watson G; Lewington O; Chadwick T; McColl E; Pearce M; Mann K; McMeekin N; Vale L; Tsui S; Yonan N; Simon A; Marczin N; Mascaro J; Dark J
    Health Technol Assess; 2016 Nov; 20(85):1-276. PubMed ID: 27897967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and severity of primary graft dysfunction after lung transplantation using rejected grafts reconditioned with ex vivo lung perfusion.
    Boffini M; Ricci D; Bonato R; Fanelli V; Attisani M; Ribezzo M; Solidoro P; Del Sorbo L; Ranieri VM; Rinaldi M
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):789-93. PubMed ID: 25061216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Adhesion Molecules During Ex Vivo Lung Perfusion Are Associated With Posttransplant Primary Graft Dysfunction.
    Hashimoto K; Cypel M; Kim H; Machuca TN; Nakajima D; Chen M; Hsin MK; Zamel R; Azad S; Waddell TK; Liu M; Keshavjee S
    Am J Transplant; 2017 May; 17(5):1396-1404. PubMed ID: 27977885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of donor related lung injury in clinical lung transplantation using a validated ex vivo lung perfusion inflammation score.
    Sage AT; Richard-Greenblatt M; Zhong K; Bai XH; Snow MB; Babits M; Ali A; Baciu C; Yeung JC; Liu M; Cypel M; Kain KC; Keshavjee S
    J Heart Lung Transplant; 2021 Jul; 40(7):687-695. PubMed ID: 33781664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating acellular versus cellular perfusate composition during prolonged ex vivo lung perfusion after initial cold ischaemia for 24 hours.
    Becker S; Steinmeyer J; Avsar M; Höffler K; Salman J; Haverich A; Warnecke G; Ochs M; Schnapper A
    Transpl Int; 2016 Jan; 29(1):88-97. PubMed ID: 26264867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extension of donor lung preservation with hypothermic storage after normothermic ex vivo lung perfusion.
    Hsin MKY; Iskender I; Nakajima D; Chen M; Kim H; Dos Santos PR; Sakamoto J; Lee J; Hashimoto K; Harmantas C; Hwang D; Waddell T; Liu M; Keshavjee S; Cypel M
    J Heart Lung Transplant; 2016 Jan; 35(1):130-136. PubMed ID: 26227444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First experience with ex vivo lung perfusion for initially discarded donor lungs in the Netherlands: a single-centre study.
    Zhang ZL; van Suylen V; van Zanden JE; Van De Wauwer C; Verschuuren EAM; van der Bij W; Erasmus ME
    Eur J Cardiothorac Surg; 2019 May; 55(5):920-926. PubMed ID: 30496383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful prolonged ex vivo lung perfusion for graft preservation in rats.
    Noda K; Shigemura N; Tanaka Y; Bhama JK; D'Cunha J; Luketich JD; Bermudez CA
    Eur J Cardiothorac Surg; 2014 Mar; 45(3):e54-60. PubMed ID: 24431161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.